INT232442

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.44
Pain Relevance 0.58

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (DDC) small molecule metabolic process (DDC) lyase activity (DDC)
cellular nitrogen compound metabolic process (DDC) cellular amino acid metabolic process (DDC) cytoplasm (DDC)
Anatomy Link Frequency
central nervous system 2
DDC (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 19 100.00 Very High Very High Very High
dopamine receptor 13 100.00 Very High Very High Very High
Dopamine 63 99.74 Very High Very High Very High
Central nervous system 8 98.80 Very High Very High Very High
Serotonin 32 95.72 Very High Very High Very High
agonist 23 95.32 Very High Very High Very High
depression 5 81.16 Quite High
Pain 2 62.84 Quite High
antidepressant 17 14.96 Low Low
sSRI 17 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Galactorrhea 124 84.76 Quite High
Depression 9 81.16 Quite High
Psychosis 17 79.00 Quite High
Anxiety Disorder 3 77.48 Quite High
Osteoporosis 1 74.04 Quite High
Reprotox - General 2 7 72.08 Quite High
Congenital Anomalies 3 70.60 Quite High
Reprotox - General 1 28 69.96 Quite High
Cleidocranial Dysplasia 1 68.44 Quite High
Macromastia 1 66.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A large group of medications can raise prolactin levels (Table 2 and Figure 2): drugs variably able of impairing central nervous system (CNS) dopaminergic function, such as false dopamine precursors, inhibitors of L-aromatic aminoacids decarboxylase and dopamine receptor antagonists, drugs enhancing serotoninergic neurotransmission, such as serotoninergic precursors, direct and indirect serotonin agonists and blockers of serotonin reuptake, histamine H2 receptor antagonists (Steiner et al 1976; Polleri et al 1980; Muller et al 1983; Di Renzo et al 1989; Molitch 2005).
Negative_regulation (inhibitors) of Gene_expression (antagonists) of L-aromatic aminoacids decarboxylase in central nervous system associated with dopamine, antagonist, dopamine receptor, agonist, central nervous system and serotonin
1) Confidence 0.05 Published 2007 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2376090 Disease Relevance 1.44 Pain Relevance 0.58

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox